Jupiter Asset Management Ltd / HTD
Jupiter Asset Management Ltd’s Corcept Therapeutics Inc Position
Does Jupiter Asset Management Ltd own Corcept Therapeutics Inc (HTD)? Not currently — the last reported position was 350.9K shares worth $29M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$29M
Q3 2025
Shares
350.9K
% of Portfolio
+0.25%
Quarters Held
15
position exited
Position History HTD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 350.9K | $29M | +0.25% |
| Q2 2025 | 601.4K | $44M | +0.37% |
| Q1 2025 | 603.9K | $69M | +0.66% |
| Q4 2024 | 7.3K | $367,696 | 0.00% |
| Q3 2024 | 256.3K | $12M | +0.10% |
| Q2 2024 | 540.7K | $18M | +0.17% |
| Q1 2024 | 744.5K | $19M | +0.18% |
| Q4 2023 | 59.6K | $2M | +0.02% |
| Q1 2022 | 220.6K | $5M | +0.06% |
| Q4 2021 | 238.5K | $5M | +0.05% |
| Q3 2021 | 241.9K | $5M | +0.05% |
| Q2 2021 | 120.5K | $3M | +0.03% |
| Q1 2021 | 120.5K | $3M | +0.03% |
| Q4 2020 | 294.1K | $8M | +0.08% |
| Q3 2020 | 648.9K | $11M | +0.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jupiter Asset Management Ltd’s full portfolio or all institutional holders of HTD.